concept

SGMS1/SGMS2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SGMS1/SGMS2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

21Connections
1Hypotheses
1Analyses
9Outgoing
12Incoming
2Experiments
1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameSGMS1/SGMS2
Key Genes/ProteinsABCA1/LDLR/SREBF2, BACE1, CYP46A1, FLOT1, LDLR, RANK
Related Diseasesneurodegeneration
Related Pathwayssphingolipid___ceramide_signaling

Pathway Diagram

graph TD
    SGMS1_SGMS2[SGMS1/SGMS2]
    SGMS1_SGMS2 -->|debate_co_mention| SMPD1[SMPD1]
    SGMS1_SGMS2 -->|debate_co_mention| SREBF2[SREBF2]
    SGMS1_SGMS2 -->|debate_co_mention| ST3GAL2[ST3GAL2]
    SGMS1_SGMS2 -->|debate_co_mention| ST8SIA1[ST8SIA1]
    SGMS1_SGMS2 -->|debate_co_mention| ST3GAL2_ST8SIA1[ST3GAL2/ST8SIA1]
    SGMS1_SGMS2 -->|implicated in| neurodegeneration[neurodegeneration]
    SGMS1_SGMS2 -->|involved_in| sphingolipid___ceramide_signal[sphingolipid___ceramide_signaling]
    SGMS1_SGMS2 -->|data_in| benchmark_ot_ad_answer_key_SGM[benchmark_ot_ad_answer_key:SGMS1/SGMS2]
    h_fdb07848[h-fdb07848] -->|targets| SGMS1_SGMS2
    CYP46A1[CYP46A1] -->|debate_co_mention| SGMS1_SGMS2
    FLOT1[FLOT1] -->|debate_co_mention| SGMS1_SGMS2
    LDLR[LDLR] -->|debate_co_mention| SGMS1_SGMS2
    neuroinflammation[neuroinflammation] -->|debate_co_mention| SGMS1_SGMS2
    RANK[RANK] -->|debate_co_mention| SGMS1_SGMS2
    SGMS1[SGMS1] -->|debate_co_mention| SGMS1_SGMS2
    ABCA1_LDLR_SREBF2[ABCA1/LDLR/SREBF2] -->|co_associated_with| SGMS1_SGMS2
    BACE1[BACE1] -->|co_associated_with| SGMS1_SGMS2

Outgoing (9)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:SGMS1/SGMS2data_indataset_row0.00
ST3GAL2/ST8SIA1debate_co_mentiongene0.45
SMPD1debate_co_mentiongene0.45
SREBF2debate_co_mentiongene0.45
ST3GAL2debate_co_mentiongene0.45

Incoming (12)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:SGMS1/SGMS2data_indataset_row0.00
h-fdb07848targetshypothesis0.50
CYP46A1debate_co_mentiongene0.45
FLOT1debate_co_mentiongene0.45
LDLRdebate_co_mentiongene0.45

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Sphingomyelin Synthase Activators for Raft Remodeling 0.692 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (1)

Scientific analyses that reference this entity

Lipid raft composition changes in synaptic neurodegeneration

neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.921

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Validation: Membrane-Nucleation in iPSC Neurons validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,100,000

Related Papers (18)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Ceramide metabolism in oxidative and glycolytic muscle: Significance for lipid-i [PMID:41707846] Eurén T, Flockhart M, Strmeň T, Zhou X, Molecular metabolism 2026 0
Effect of Lactiplantibacillus mudanjiangensis strain isolated from post-fermente [PMID:41270786] Horie M, Tabata Y, Aiso C, Gotoh Y Beneficial microbes 2025 0
Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078] ["Ranjitha V", "Kumar A", "Kaalappa P"] Pharmaceutical research 2025 0
Identification of Anticancer Target Combinations to Treat Pancreatic Cancer and [PMID:40807373] ["Wang F", "Wu C", "Huang K"] Molecules (Basel, Switzerland) 2025 0
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] ["Sanadgol N", "Abedi M", "Hashemzaei M" Journal of nanobiotechnology 2025 0
Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardi [PMID:37298446] Gruzdeva O, Dyleva Y, Belik E, Uchasova International journal of molec 2023 0
Airway Resistance Caused by Sphingomyelin Synthase 2 Insufficiency in Response t [PMID:31517509] Gupta G, Baumlin N, Poon J, Ahmed B, Chi American journal of respirator 2020 0
Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disru [PMID:30770781] Zheng K, Chen Z, Feng H, Chen Y, Zhang C Cell death & disease 2019 0
Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid R [PMID:31114500] Bilal F, Montfort A, Gilhodes J, Garcia Frontiers in pharmacology 2019 0
Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2. [PMID:30779713] Pekkinen M, Terhal PA, Botto LD, Henning JCI insight 2019 0
Health status of long-term sick leave and working female teachers in Germany: A [PMID:29063910] ["Br\u00fctting J", "Druschke D", "Spitz International journal of occup 2018 0
Tuning CRISPR-Cas9 Gene Drives in [PMID:29348295] ["Roggenkamp E", "Giersch R", "Schrock M G3 (Bethesda, Md.) 2018 0
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneou [PMID:28916600] ["Shah B", "Baber U", "Pocock S", "Kruco Circulation. Cardiovascular in 2017 0
Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impa [PMID:28186978] ["Liu M", "Zhao M", "Kong W", "Tang L", Oncotarget 2017 0
Single-cell RNAseq reveals cell adhesion molecule profiles in electrophysiologic [PMID:27531958] ["F\u00f6ldy C", "Darmanis S", "Aoto J", Proceedings of the National Ac 2016 0
Delayed coupling to feedback inhibition during a critical period for the integra [PMID:25533485] ["Temprana S", "Mongiat L", "Yang S", "T Neuron 2015 0
Ascidians as excellent models for studying cellular events in the chordate body [PMID:23995746] ["Ogura Y", "Sasakura Y"] The Biological bulletin 2013 0
Nutrient-induced insulin resistance in human skeletal muscle. [PMID:15078172] ["Krebs M", "Roden M"] Current medicinal chemistry 2004 0

Debates (1)

Multi-agent debates referencing this entity

Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) c

closed · Rounds: 5 · Score: 0.93 · 2026-04-11

Related Research

Hypotheses and analyses mentioning SGMS1/SGMS2 in their description or question text

No additional research found